Showing results (1-10 of 216) with videos related to
Sort By:
Pageof 22
Nature Reviews. Clinical Oncology|October 4, 2024
The high costs of anticancer therapies in the USA: challenges, opportunities and progressShelley A Jazowski, Rahul K Nayak, Stacie B DusetzinaPharmacoepidemiology and Drug Safety|September 12, 2019
Initiation of generic imatinib may improve medication adherence for patients with chronic myeloid leukemiaAshley L Cole, Shelley A Jazowski, Stacie B DusetzinaJAMA Network Open|December 9, 2025
Health Care Contact Days in Older Adults With Metastatic CancerArjun Gupta, Shelley A Jazowski, Avirath U Vaidya, et al.JAMA Network Open|June 7, 2022
Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple MyelomaShelley A Jazowski, Lauren Wilson, Stacie B Dusetzina, et al.Journal of Health Politics, Policy and Law|July 22, 2022
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical BenefitsRachel E Sachs, Shelley A Jazowski, Kyle A Gavulic, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 14, 2025
Inequities in supportive care medication use among older adults with metastatic pancreatic adenocarcinomaAlvina Liang, Avirath U Vaidya, Robert J Besaw, et al.JAMA Health Forum|August 17, 2022
Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending CapsStacie B Dusetzina, Haiden A Huskamp, Shelley A Jazowski, et al.Health Affairs Scholar|January 22, 2025
Estimating financial and health burden by initial Medicare plan choice and history of cancerShelley A Jazowski, Emma M Achola, Lauren Hersch Nicholas, et al.Health Affairs Scholar|May 17, 2024
Comparing Medicare plan selection among beneficiaries with and without a history of cancerShelley A Jazowski, Emma M Achola, Lauren H Nicholas, et al.The American Journal of Managed Care|May 25, 2023
Association between low-income subsidies and inequities in orally administered antimyeloma therapy useShelley A Jazowski, Cleo A Samuel-Ryals, William A Wood, et al.Pageof 22